Skip to main content
search
0

Mayzent (Siponimod)

  • Medicine Name: Mayzent
  • API: Siponimod
  • Dosage Form & Strength: Tablets: 0.25 mg, 1 mg, and 2 mg
  • Manufactured By: Novartis Pharmaceuticals

Medical Uses

Mayzent (siponimod) is a sphingosine 1-phosphate (S1P) receptor modulator used for the treatment of adult patients with relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.

Mayzent (siponimod) is a sphingosine 1-phosphate (S1P) receptor modulator used for the treatment of adult patients with relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.

Recommended Dosage: The recommended maintenance dosage of Siponimod is 2 mg taken orally. The recommended maintenance dosage in patients with a CYP2C9*1/*3 or *2/*3 genotype is 1 mg. Tablets should be taken whole; do not split, crush, or chew. Assessments are needed before initiating this oral therapy.
First-dose monitoring is required for patients with sinus bradycardia, first- or second-degree [Mobitz type I] atrioventricular (AV) block, or a known history of myocardial infarction or heart failure.

Warning & Precautions

  • Treatment with Siponimod can make it difficult for your body to combat infections. Watch out for symptoms like fever, chills, or cough. If you feel unwell, contact your doctor immediately to check for any possible infections caused by the medication.
  • PML is a very serious brain infection that can happen while taking Siponimod. Symptoms may include memory loss, confusion, or difficulty speaking. In case you notice these, stop taking the medicine and contact your healthcare provider (HCP) urgently.
  • This medication can cause swelling in the macula, the central part of your retina, which may lead to vision problems. If you notice blurry vision, shadows, or difficulty seeing, especially if you have diabetes, tell your doctor promptly for an eye exam.
  • Siponimod may slow your heart rate or cause problems with how electrical signals pass through your heart. This is more likely when starting treatment. Your heart should be monitored closely by your doctor during the initial hours of taking this medication.
  • This therapy may slightly affect your lungs and breathing. This could worsen if you already have asthma or chronic lung disease. If you experience shortness of breath, coughing, or wheezing, consult your doctor quickly for further medical evaluation.
  • Liver problems may occur with Siponimod. Symptoms like yellowing of the skin or eyes, dark urine, or severe tiredness need urgent medical attention. Your liver function should be checked through regular blood tests during the treatment.
  • Taking this therapeutic drug may increase your risk of skin cancer. Use sunscreen and protective clothing when going outside. If you notice new growths, moles changing size or color, or any skin changes, inform your doctor as soon as possible.
  • This medicinal product may cause a rise in blood pressure over time. It is essential to check your blood pressure regularly while on this medication. If you feel dizzy, have headaches, or notice changes, speak to your doctor promptly.
  • Siponimod can harm an unborn baby. Women who can become pregnant must use reliable birth control during treatment and for at least ten days after stopping the medication. Always talk to your doctor if you plan to become pregnant.

Documentation & Availability

What documents are required to import MAYZENT to India?

MAYZENT (siponimod) tablets can be imported by patients or government hospitals in the patients' name only.
The following documentation is required to import the product:

  • A valid prescription from a qualified doctor.
  • Patients diagnostic reports
  • Patient ID proof (issued by the government of India)
How does the order be confirmed?

The order will be confirmed only after the receipt of:

  • A valid prescription from the Doctor
  • Import permit if applicable
Is MAYZENT available in India?

MAYZENT (siponimod tablet) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input

  • On availability of Mayzent in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
  • On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
    Medicine Price.
  • Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
  • Ensuring 100% transparency.

MAYZENT can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of MAYZENT (prescription medicines) to all locations in the world and India after fulfilling the legal requirement (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Mayzent tablet 1 mg/2 mg price in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Sourcing & Delivery

Indian Pharma Network can source MAYZENT (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient's address only from New Delhi, India.

FAQ

What is the Generic Name for the trade name drug Mayzent®?

Siponimod is a Generic Name for the trade name drug Mayzent®.

What is the Manufacturer's Name of Mayzent®?

Mayzent® is manufactured by Novartis Pharmaceuticals.

Is Mayzent® approved by the FDA?

Yes, Mayzent® is approved by the FDA. Date of first approval: March 26, 2019.

What is the dosage and form of Mayzent® supplied?

Mayzent is supplied in Tablets of 0.25 mg, 1 mg, and 2 mg for oral administration.

What are the most common side effects of Mayzent®?

The most common side effects of Mayzent® are headache, transaminase increase, and hypertension.

How much does the Mayzent® tablet cost in India?

Prices of Mayzent may fluctuate over time due to market dynamics and regulatory changes. To get the most accurate and latest details on Mayzent 0.25 mg/1 mg/2 mg cost in India, please Call/WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

Can Mayzent® be available in SAARC countries?

Apart from Gulf countries, Mayzent® can be available in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Mayzent® tablets in these countries. We help ensure legal access to this therapeutic drug through our reliable channels.

Is it safe to buy Mayzent® Tablets online in India?

Yes, one can buy Mayzent online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can help facilitate the supply of Mayzent® oral tablets through legal channels.

What are the storage conditions of Mayzent® 0.25 mg, 1 mg, and 2 mg tablets?

Store 0.25 mg, 1 mg, and 2 mg tablets at room temperature, between 20°C and 25°C, in a tightly closed container. Keep away the tablets from moisture, heat, and direct sunlight.

Contact Patient Support

If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.

Disclaimer

All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.

Close Menu

Product Enquiry